AffRegInc.i
Curation
Accueil
Racine
Curation
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Sendai »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Selangor < Sendai < Sendai  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000052 (2020) Yasuhiko Hirabayashi [Japon]Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.
000140 (2020) Yusho Ishii [Japon] ; Hiroshi Fujii [Japon] ; Koichiro Sugimura [Japon] ; Tsuyoshi Shirai [Japon] ; Yosuke Hoshi [Japon] ; Yoko Fujita [Japon] ; Yuko Shirota [Japon] ; Tomonori Ishii [Japon] ; Hiroaki Shimokawa [Japon] ; Hideo Harigae [Japon]Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody
000190 (2020) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Some concerns from Turkey' by Bilgin et al.
000479 (2020) Masaaki Yoshida [Japon] ; Takehiro Hariya [Japon] ; Shunji Yokokura [Japon] ; Wataru Kobayashi [Japon] ; Ryu Watanabe [Japon] ; Tomonori Ishii [Japon] ; Toru Nakazawa [Japon]Concomitant herpes simplex keratitis and autoimmune-associated ulcerative keratitis in rheumatoid arthritis patients
000905 (2019) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.
000921 (2019) Tomoyuki Mutoh [Japon] ; Tomonori Ishii [Japon] ; Tsuyoshi Shirai [Japon] ; Kanae Akita [Japon] ; Yukiko Kamogawa [Japon] ; Yoko Fujita [Japon] ; Hiroko Sato [Japon] ; Yuko Shirota [Japon] ; Hiroshi Fujii [Japon] ; Hideo Harigae [Japon]Refractory Takayasu arteritis successfully treated with rituximab: case-based review.
001129 (2018) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonoti Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.
001396 (2018) Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon]Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
001D28 (2016) Masaaki Yoshida [Japon] ; Ryu Watanabe [Japon] ; Tomonori Ishii [Japon] ; Tomoaki Machiyama [Japon] ; Kanae Akita [Japon] ; Yoko Fujita [Japon] ; Yuko Shirota [Japon] ; Koichiro Sugimura [Japon] ; Hiroshi Fujii [Japon] ; Hiroaki Shimokawa [Japon] ; Hideo Harigae [Japon]Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience
001F51 (2015) Carole Henique [France] ; Guillaume Bollee [France, Canada] ; Olivia Lenoir [France] ; Neeraj Dhaun [France, Royaume-Uni] ; Marine Camus [France] ; Anna Chipont [France] ; Kathleen Flosseau [France] ; Chantal Mandet [France] ; Masayuki Yamamoto [Japon] ; Alexandre Karras [France] ; Eric Thervet [France] ; Patrick Bruneval [France] ; Dominique Nochy [France] ; Laurent Mesnard [France] ; Pierre-Louis Tharaux [France]Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN
002601 (2014) Douglas Kazutoshi Sato [Japon] ; Dagoberto Callegaro [Brésil] ; Frederico M. De Haidar Jorge [Brésil] ; Ichiro Nakashima [Japon] ; Shuhei Nishiyama [Japon] ; Toshiyuki Takahashi [Japon] ; Renata Faria Simm [Brésil] ; Samira Luisa Apostolos-Pereira [Brésil] ; Tatsuro Misu [Japon] ; Lawrence Steinman [États-Unis] ; Masashi Aoki [Japon] ; Kazuo Fujihara [Japon]Cerebrospinal fluid aquaporin‐4 antibody levels in neuromyelitis optica attacks
002F42 (2013) Douglas Kazutoshi Sato [Japon] ; Marco Aurelio Lana-Peixoto [Brésil] ; Kazuo Fujihara [Japon] ; Jerome De Seze [France]Clinical Spectrum and Treatment of Neuromyelitis Optica Spectrum Disorders: Evolution and Current Status
003191 (2013) R. Watanabe ; H. Okuno ; T. Ishii ; H. Harigae ; Y. Hirabayashi [Japon]AB0330 Long-term administration of tocilizumab increases the structural remission rate year by year and continuously inhibits radiographic progression: 3 year results from michinoku tocilizumab study group
003611 (2012) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
003662 (2012) Kazuo Fujihara [Japon] ; Tatsuro Misu [Japon] ; Ichiro Nakashima [Japon] ; Toshiyuki Takahashi [Japon] ; Monika Bradl [Autriche] ; Hans Lassmann [Autriche] ; Rina Takano [Japon] ; Shuhei Nishiyama [Japon] ; Yoshiki Takai [Japon] ; Chihiro Suzuki [Japon] ; Douglas Sato [Japon] ; Hiroshi Kuroda [Japon] ; Masashi Nakamura [Japon] ; Juichi Fujimori [Japon] ; Koichi Narikawa [Japon] ; Shigeru Sato [Japon] ; Yasuto Itoyama [Japon] ; Masashi Aoki [Japon]Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
004011 (2009) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Sendai" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Sendai" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Sendai
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021